Efficacy of Vonoprazan for Gastroesophageal Reflux Symptoms in Patients with Proton Pump Inhibitor-resistant Non-erosive Reflux Disease

OBJECTIVE: Clinically, patients with proton pomp inhibitor (PPI)-resistant gastroesophageal reflux disease (GERD) are very challenging to treat. The aim of this study was to determine the rates of symptom relief and adverse events among PPI-resistant GERD patients that changed their therapy from a P...

Descripción completa

Detalles Bibliográficos
Autores principales: Niikura, Ryota, Yamada, Atsuo, Hirata, Yoshihiro, Hayakawa, Yoku, Takahashi, Akihiro, Shinozaki, Tomohiro, Takeuchi, Yoshinori, Fujishiro, Mitsuhiro, Koike, Kazuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6172555/
https://www.ncbi.nlm.nih.gov/pubmed/29607951
http://dx.doi.org/10.2169/internalmedicine.0492-17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6172555/
https://www.ncbi.nlm.nih.gov/pubmed/29607951
http://dx.doi.org/10.2169/internalmedicine.0492-17

Ejemplares similares